Macrophage/cancer cell interactions mediate hormone resistance by a nuclear receptor derepression pathway.
about
Androgen-targeted therapy-induced epithelial mesenchymal plasticity and neuroendocrine transdifferentiation in prostate cancer: an opportunity for interventionSirtuin 1 is required for antagonist-induced transcriptional repression of androgen-responsive genes by the androgen receptorProhibitin and the SWI/SNF ATPase subunit BRG1 are required for effective androgen antagonist-mediated transcriptional repression of androgen receptor-regulated genesPromyelocytic leukemia protein interacts with the apoptosis-associated speck-like protein to limit inflammasome activationA histone H2A deubiquitinase complex coordinating histone acetylation and H1 dissociation in transcriptional regulationHistone deacetylase 7 and FoxA1 in estrogen-mediated repression of RPRMThe cell fate determination factor dachshund inhibits androgen receptor signaling and prostate cancer cellular growthLigand-specific dynamics of the androgen receptor at its response element in living cellsParallel SUMOylation-dependent pathways mediate gene- and signal-specific transrepression by LXRs and PPARgammaMinireview: Inflammation: an instigator of more aggressive estrogen receptor (ER) positive breast cancersA Novel Functional Domain of Tab2 Involved in the Interaction with Estrogen Receptor Alpha in Breast Cancer CellsLigand structural motifs can decouple glucocorticoid receptor transcriptional activation from target promoter occupancyMacrophage diversity enhances tumor progression and metastasisEstrogen and inflammation modulate estrogen receptor alpha expression in specific tissues of the temporomandibular joint.Partners in crime: deregulation of AR activity and androgen synthesis in prostate cancerMolecular genetics of prostate cancer: new prospects for old challengesProinflammatory cytokines enhance estrogen-dependent expression of the multidrug transporter gene ABCG2 through estrogen receptor and NF{kappa}B cooperativity at adjacent response elements.Glucocorticoid receptor cofactors as therapeutic targets.Androgen receptor, ccl2, and epithelial-mesenchymal transition: A dangerous affair in the tumor microenvironmentEstrogen-occupied estrogen receptor represses cyclin G2 gene expression and recruits a repressor complex at the cyclin G2 promoter.Noncanonical Wnt signaling mediates androgen-dependent tumor growth in a mouse model of prostate cancer.What goes on behind closed doors: physiological versus pharmacological steroid hormone actions.The role of cytokines in breast cancer development and progressionNurr1 represses tyrosine hydroxylase expression via SIRT1 in human neural stem cellsTargeting TR4 nuclear receptor suppresses prostate cancer invasion via reduction of infiltrating macrophages with alteration of the TIMP-1/MMP2/MMP9 signals.Analyzing serum-stimulated prostate cancer cell lines after low-fat, high-fiber diet and exercise intervention.CSF1 receptor targeting in prostate cancer reverses macrophage-mediated resistance to androgen blockade therapy.New hormonal therapies for castration-resistant prostate cancer.Macrophage-dependent cleavage of the laminin receptor α6β1 in prostate cancer.NFκB affects estrogen receptor expression and activity in breast cancer through multiple mechanisms.Macrophage-elicited loss of estrogen receptor-α in breast cancer cells via involvement of MAPK and c-Jun at the ESR1 genomic locus.Androgen receptor decoy molecules block the growth of prostate cancerMechanisms mediating androgen receptor reactivation after castration.Sensitive ChIP-DSL technology reveals an extensive estrogen receptor alpha-binding program on human gene promoters.The human myeloperoxidase gene is regulated by LXR and PPARalpha ligands.Tumor signaling to the bone marrow changes the phenotype of monocytes and pulmonary macrophages during urethane-induced primary lung tumorigenesis in A/J miceKinases and protein phosphorylation as regulators of steroid hormone actionIdentification of two novel mammographic density loci at 6Q25.1.Radiation, inflammation, and immune responses in cancerHistone methylation-dependent mechanisms impose ligand dependency for gene activation by nuclear receptors.
P2860
Q21129293-8F09BA6A-D310-4617-B106-4F5F31CF5E97Q24306066-A7CFF9E9-03C2-45C9-80D8-690D7FC71D53Q24314424-71323D68-ADAC-4C73-8F79-4E680EAD17EAQ24318667-E392CD19-C086-4F78-9FDB-A31285632AE5Q24337802-5F8D82C8-64C0-42CB-A1E1-DBB6E4D8E975Q24653898-E155A6BA-87C8-42A9-9B58-13B7843913DFQ24658169-3FCE0BBA-E731-4CC7-BA22-2D7E811D2E38Q24681534-D791DEBA-0082-4A93-9C4B-7DC23649FDDAQ24685818-207AE9FF-25DA-4F35-841F-8B9F3A5B3B73Q27016106-68AD1A3B-BB3A-48D5-B90E-2548577111E9Q28555115-D4A7069F-676C-41A5-A8E1-D95361FCEB97Q28568722-76BDCFD5-726E-432E-9281-7779FE05F90CQ29615847-BC0780D1-FA3F-4C00-99C4-50426B82E771Q33521510-EC616E15-34E5-4C90-B5FC-860D9500D942Q33823702-AD939CDF-CCCC-45F5-9C9B-0E438B7D779EQ34127462-55014736-8B23-4B54-8984-58E55536E1A3Q34181200-CB61276D-B9E6-445D-9037-06C4FAE6D6B5Q34311390-960390EE-A167-4B26-9CFF-E24EFD9AE42AQ34373051-EA685737-25AD-47D1-9EE3-C2F890C44C0DQ34512836-AF3D4E76-3BCD-400F-B024-6708792FE65AQ34720933-A97EEEF4-EFD5-4F6F-A55D-BDF5AC71E164Q34795516-55BC8CE6-E1E3-415E-8E18-D5F949901438Q34920381-661C0CD3-4A1D-4384-B950-C1FB6F5E69FEQ34971173-9201111D-529C-4DB7-AE80-8E92286EC8D3Q35048121-6AE12534-E8EA-4B5C-886F-2FABA582786FQ35103739-FF003984-5912-43CF-9CF3-F2E34ADEA569Q35178381-53F9723E-498A-404E-B529-C6081C403C66Q35196715-32FFB6CC-F47D-4168-B2FC-89EC576689A1Q35388139-E51F46C9-724C-427B-9F89-98663216B309Q35469769-63C93E77-3A30-4603-A428-16A89BBD90E7Q35571726-143CD1F4-AC0A-4864-9B59-01B3B0AEC88CQ35611734-C8B4C6C0-9FD0-442E-A629-B9C8E1AF9BEEQ35633454-276ED4C0-EE16-4ADE-B2DE-B913802D90EAQ35677829-3C8AE6B4-5AF7-404E-B84B-45B67CF3B0C0Q35697554-2283AB6F-86AC-4616-B3D4-978A2AE1817CQ35750139-148FE668-F018-4923-B24B-D163A068D339Q35809009-6DD9ADCD-4BBD-434C-868D-001D0964FC04Q35848934-9BD41F81-1D8C-4E9A-85FC-E6F7C2B9121DQ36005646-A0CC91A6-2F6C-48DD-857C-8772C72AE557Q36014589-6D227237-4C8D-4F25-938A-3BA36FE8EF10
P2860
Macrophage/cancer cell interactions mediate hormone resistance by a nuclear receptor derepression pathway.
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Macrophage/cancer cell interac ...... receptor derepression pathway.
@ast
Macrophage/cancer cell interac ...... receptor derepression pathway.
@en
Macrophage/cancer cell interac ...... receptor derepression pathway.
@nl
type
label
Macrophage/cancer cell interac ...... receptor derepression pathway.
@ast
Macrophage/cancer cell interac ...... receptor derepression pathway.
@en
Macrophage/cancer cell interac ...... receptor derepression pathway.
@nl
prefLabel
Macrophage/cancer cell interac ...... receptor derepression pathway.
@ast
Macrophage/cancer cell interac ...... receptor derepression pathway.
@en
Macrophage/cancer cell interac ...... receptor derepression pathway.
@nl
P2093
P1433
P1476
Macrophage/cancer cell interac ...... receptor derepression pathway.
@en
P2093
Christopher K Glass
David W Rose
Eliot M Bourk
Hideki Sanjo
Ivan Garcia-Bassets
Kenneth A Ohgi
Michael G Rosenfeld
Paul F Kotol
Sung Hee Baek
P304
P356
10.1016/J.CELL.2005.12.032
P407
P50
P577
2006-02-01T00:00:00Z